2B78.DE vs. LHTC.DE
2B78.DE (iShares Healthcare Innovation UCITS ETF) and LHTC.DE (Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc) are both Health & Biotech Equities funds - 2B78.DE tracks the iSTOXX® FactSet Breakthrough Healthcare while LHTC.DE tracks the STOXX® Europe 600 Health Care. Both are passively managed. Over the past 5 years, 2B78.DE returned -1.74%/yr vs 5.04%/yr for LHTC.DE. A 0.62 correlation means they provide meaningful diversification when combined. 2B78.DE charges 0.40%/yr vs 0.30%/yr for LHTC.DE.
Performance
2B78.DE vs. LHTC.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B78.DE achieves a -2.07% return, which is significantly higher than LHTC.DE's -2.55% return.
2B78.DE
- 1D
- 0.41%
- 1M
- 1.41%
- YTD
- -2.07%
- 6M
- -3.15%
- 1Y
- 14.42%
- 3Y*
- 2.27%
- 5Y*
- -1.74%
- 10Y*
- —
LHTC.DE
- 1D
- 3.03%
- 1M
- 1.33%
- YTD
- -2.55%
- 6M
- -0.81%
- 1Y
- 5.03%
- 3Y*
- 2.35%
- 5Y*
- 5.04%
- 10Y*
- 5.88%
2B78.DE vs. LHTC.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
2B78.DE iShares Healthcare Innovation UCITS ETF | -2.07% | 5.50% | 7.24% | -0.29% | -19.03% | 1.15% | 38.75% | 16.74% | 0.39% | 19.45% |
LHTC.DE Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc | -2.55% | 7.11% | 3.92% | 7.59% | -6.20% | 25.48% | -1.95% | 27.54% | 2.95% | 4.36% |
Correlation
The correlation between 2B78.DE and LHTC.DE is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.68 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Sep 14, 2016 | 0.62 |
The correlation between 2B78.DE and LHTC.DE has been stable across timeframes, ranging from 0.59 to 0.68 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B78.DE vs. LHTC.DE — Risk / Return Rank
2B78.DE
LHTC.DE
2B78.DE vs. LHTC.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF (2B78.DE) and Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B78.DE | LHTC.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.65 | ||
| Sortino ratioReturn per unit of downside risk | +0.88 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.07 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.24 | 0.40 | +0.83 |
| Martin ratioReturn relative to average drawdown | 3.07 | 0.89 | +2.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B78.DE | LHTC.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 0.30 | +0.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.10 | 0.32 | -0.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.38 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.44 | -0.13 |
Drawdowns
2B78.DE vs. LHTC.DE - Drawdown Comparison
The maximum 2B78.DE drawdown since its inception was -38.58%, roughly equal to the maximum LHTC.DE drawdown of -40.53%. Use the drawdown chart below to compare losses from any high point for 2B78.DE and LHTC.DE.
Loading charts...
Drawdown Indicators
| 2B78.DE | LHTC.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.58% | -40.53% | +1.95% |
Max Drawdown (1Y)Largest decline over 1 year | -12.05% | -12.43% | +0.38% |
Max Drawdown (3Y)Largest decline over 3 years | -25.32% | -26.48% | +1.16% |
Max Drawdown (5Y)Largest decline over 5 years | -36.99% | -26.48% | -10.51% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.48% | — |
Current DrawdownCurrent decline from peak | -19.03% | -11.60% | -7.43% |
Average DrawdownAverage peak-to-trough decline | -14.36% | -9.31% | -5.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.86% | 5.67% | -0.81% |
Volatility
2B78.DE vs. LHTC.DE - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF (2B78.DE) is 3.74%, while Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE) has a volatility of 5.69%. This indicates that 2B78.DE experiences smaller price fluctuations and is considered to be less risky than LHTC.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B78.DE | LHTC.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.74% | 5.69% | -1.95% |
Volatility (6M)Calculated over the trailing 6-month period | 10.97% | 11.67% | -0.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.67% | 16.60% | -0.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.91% | 15.44% | +2.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.79% | 15.57% | +3.22% |
2B78.DE vs. LHTC.DE - Expense Ratio Comparison
2B78.DE has a 0.40% expense ratio, which is higher than LHTC.DE's 0.30% expense ratio.
Dividends
2B78.DE vs. LHTC.DE - Dividend Comparison
Neither 2B78.DE nor LHTC.DE has paid dividends to shareholders.
Frequently Asked Questions
2B78.DE and LHTC.DE have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LHTC.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LHTC.DE is cheaper with a 0.30% expense ratio, compared with 0.40% for 2B78.DE.
2B78.DE tracks iSTOXX® FactSet Breakthrough Healthcare, while LHTC.DE tracks STOXX® Europe 600 Health Care. They also come from different issuers: iShares and Amundi. Their fees differ too: 0.40% for 2B78.DE and 0.30% for LHTC.DE.
Find the right allocation for 2B78.DE and LHTC.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer